It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Thermo Fisher Scientific Inc. (TMO) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $559.44. The Thermo Fisher Scientific Inc. has recorded 162,484 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Thermo Fisher Scientific Inc. is listed on the NYSE in the Healthcare sector while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $559.44 and fluctuated between $560.53 as its day high and $549.62 as its day low. The current market capitalization of Thermo Fisher Scientific Inc. is $211.51B. A total of 1.15 million shares were traded on the day, compared to an average of 1.46M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, TMO has seen 2 BUY and 5 SELL insider trades, representing the acquisition of 4,975 and the disposition of 8,175 shares. Over the last 12 months, there were 37 BUYs and 271 SELLs from insiders. Insiders purchased 223,709 shares during that period but sold 274,811.
In the most recent transaction, CASPER MARC N sold 1,600 shares of TMO for 571.96 per share on Feb 14. After the transaction, the Chairman & CEO now owns 128,705 company shares. In a previous transaction on Feb 13, CASPER MARC N sold 10,000 shares at 574.48 per share. TMO shares that Chairman & CEO owns now total 128,705.
Among the insiders who sold shares, CASPER MARC N disposed of 20,000 shares on Feb 10 at a per-share price of $569.18. This resulted in the Chairman & CEO holding 128,705 shares of TMO after the transaction. In another insider transaction, CASPER MARC N sold 20,000 shares at $575.43 per share on Feb 09. Company shares held by the Chairman & CEO now total 138,705.
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Thermo Fisher Scientific Inc. pays an annual dividend of $1.40, resulting in a dividend yield of 0.25%, and it has a price to earnings (P/E) ratio of 31.72. TMO’s most recent ex-dividend date was 3/14/2023 when it declared a $0.35 quarterly dividend that was paid in cash on 4/14/2023. Previously, the company paid the dividend on 1/16/2023 with an ex-dividend date of 12/14/2022. The TMO stock dividend was $0.30 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for TMO in the last 3 months, the mean price target is $651.95 with high estimates of $711.00 and low estimates of $505.00. In terms of 52-week highs and lows, TMO has a high of $618.35 and a low of $475.77.
As of this writing, TMO has an earnings estimate of $5.05 per share for the current quarter. EPS was calculated based on a consensus of 21 estimates, with a high estimate of $5.85 per share and a lower estimate of $4.78. The company reported an EPS of $5.08 in the last quarter, which was 5.60% higher than expectations of $4.81.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Sell with a score of 4.38. A total of 15 analysts rated the stock as Buy while 3 rated it as Overweight while 5 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.